This study is observing patients for up to 7 years after they received a special eye implant during cataract surgery. The implant is designed to both improve vision and continuously release medication to control high eye pressure from glaucoma. Researchers want to see if the impl…
Sponsor: SpyGlass Pharma, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC